XRP Healthcare Magazine Turns One !
Dear Readers,
As we unveil the fifth issue of XRP Healthcare Magazine, we proudly celebrate our first anniversary. What started in November 2023 as a platform to update a growing community has quickly evolved into a trusted resource for healthcare professionals, investors, and innovators. Over the past year, we have provided insights into company progress, AI, blockchain advancements, and healthcare investments, shaping conversations in the industry.
A key driver of XRP Healthcare Magazine’s growth and influence has been the strong partnerships we have forged across the healthcare industry. Collaborations with Aramex have enabled global distribution of our print edition, while strategic alliances with Expo Group have expanded our visibility at major events like Medexpo and Medic East Africa. Additionally, partnerships with Foventa’s All Things Lab and Testing Expo (ATLT), ACE Group, and Genesis Global Exhibitions have reinforced our role as a trusted media partner, further solidifying our presence in the global healthcare space.
Alongside our print edition, the launch of www. xrphmagazine.ai has created a digital hub for breaking healthcare news and industry updates. With a growing audience, we are committed to expanding strategic collaborations, and sharing transformative stories and trends in the healthcare space.
its TSX Ventures Exchange listing, marking a major milestone in the company’s growth.
We also feature an exclusive interview with Kain Roomes and Laban Roomes, sharing their journey of working together as father and son. They reflect on the tremendous achievements made in just two years, including their thoughts on XRP Healthcare going public and other exciting insights from their personal experiences.
This special anniversary issue features exclusive insights from ARC Group executives, the experts driving XRP Healthcare’s public listing. Their team—Abraham Cinta (CEO), Andrew Bell (Director & CIO), Brandon Goodwin (Vice President - Middle East), and Charles Chong (Vice President of EMEA Capital Markets)—has played a key role in guiding XRP Healthcare toward
Special thanks to:
EXECUTIVE TEAM
Board/Team Members
FOUNDER
Kain Roomes
CO-FOUNDER
Laban Roomes
Another exciting development is XRP Healthcare’s first acquisition in Uganda, acquiring Pharma Ville Ltd., a well-established pharmacy chain. This move strengthens XRP Healthcare’s mission to modernize and expand private pharmaceutical services across Africa, improving accessibility, efficiency, and affordability for patients.
As we reflect on this journey, we are grateful for the support of our readers, partners, and contributors. Your engagement drives our commitment to delivering meaningful and impactful content. We look forward to another year of growth, innovation, and shaping the future of healthcare.
Wishing you all a prosperous 2025!
Warm regards,
Benjamin Opuko Chief Editor, XRP Healthcare Magazine
EDITOR Benjamin Opuko
JOURNALIST
Hellen Mucheru
GRAPHIC DESIGNER
Cynthia Achieng’
PUBLISHED BY: XRP HEALTHCARE
LOCATION: Meydan Grandstand, 6th Floor, Meydan Road, Nad Al Sheba, Dubai, UAE
EMAIL : Press.@xrphealthcare.com
WEBSITE: www.xrphealthcare.ai
20. ABRAHAM CINTA
26. ANDREW BELL
32. CHARLES CHONG Director & CIO of ARC Group ARC Group CEO ARC Group’s VP of Operations EMEA
ACQUISITION
XRP Healthcare Marks First Acquisition of Pharmacy chain store in Uganda
Founders Laban & Kain Roomes of XRP Healthcare
Group VP Middle East Life, Legacy & Global Impact
BRANDON GOODWIN 37. DR. PETER WAISWA
Founders Laban & Kain Roomes on XRP Healthcare Going Public
BY BENJAMIN OPUKO
L to R: Kain Roomes (CEO) & Laban Roomes (COO & Co-Founder), XRP Healthcare
In this exclusive interview, we sat down with the dynamic duo behind XRP Healthcare—the visionary CEO – Kain Roomes, and the strategic COO— Laban Roomes to delve into their groundbreaking global announcement. As the company prepares to go public and unveil its first acquisition, they reflect on their incredible two-year journey as a father-and-son team, the milestones they’ve achieved, and the transformative potential of their innovative healthcare model. From blockchain and AI integration to the anticipated ripple effects on the XRPH token, this is a mustread for investors, healthcare professionals, and technology enthusiasts eager to glimpse the future of healthcare.
XRPH Press: How has the journey been working on this unique project alongside your father over the past two years? What challenges and triumphs have stood out the most?
Kain: The journey of working alongside my dad over the past two years has been nothing short of phenomenal. We have a natural connection— our dynamic just works. Honestly, we wouldn’t be doing this together if it didn’t. It is iron sharpens iron, and that’s exactly what we are for each other— challenging, inspiring, and elevating one another.
What makes this partnership even more special is how rare it is, especially within the Black community. The bond we share, both as family and business partners, is something I truly cherish. It’s the perfect balance—my dad brings a wealth of wisdom and experience, and I bring my own fresh perspective. Together, it’s a synergy that keeps us moving forward.
At the core of it all is trust. I naturally trust my dad, and he trusts me. That foundation allows us to move with confidence, knowing we have each other’s best interests at heart. It’s rare to find a business partner where trust is absolute—there’s no second-guessing, no hidden agendas. Just two people aligned in vision, working toward the same goal. That’s a huge advantage.
Of course, we don’t always see eye to eye. There are moments of disagreement—some heated debates even—but what makes it work is how quicklywe resolve them. We never let things linger; we’re both focused on keeping the energy positive and productive.
The challenges? There have been plenty—countless, even—but every obstacle has taught us something valuable. We’ve always found a way to navigate through them. That’s the beauty of this journey. No matter how big the hurdles, I genuinely believe there’s nothing we can’t accomplish together.
XRPH Press: Achieving such remarkable milestones in just two years is no small feat. How do you feel about these achievements, and what do they signify for you as a leader?
Kain: Achieving these milestones in just over two years feels incredible. It reflects who I am at my core—a winner. I’ve always had that drive; it’s been a part of me since childhood, so seeing these accomplishments come to life is deeply gratifying. It’s not just about the success itself; it’s about the journey, the resilience, and the ability to push through challenges.
One thing that sticks with me is when my dad said, out of all the many business partners he’s had in his life, I’m the best partner he’s ever had. That kind of statement means a lot, and it reassures me that we must be doing something right.
What makes it even more meaningful is that there were people who didn’t believe in me—people who doubted the vision and underestimated what we could achieve. Honestly, that’s been a huge motivator for me. Proving them wrong has only fueled my determination to keep pushing harder and going further,
As a leader, these milestones reaffirm my belief in our mission and the impact we’re making. They also remind me that this is just the beginning—there’s so much more to accomplish, and I’m more energized than ever to keep building and breaking new ground
XRPH Press: On a personal level, what does taking XRP Healthcare public mean to you? How does this milestone align with your vision for the company?
Kain: This milestone aligns perfectly with my vision for XRP Healthcare because it positions us on a global stage, providing the resources and visibility needed to create an even greater impact. Going
public enables us to scale faster, expand our reach, and solidify our position as a leader in transforming healthcare, especially in underserved regions.
It’s also about breaking barriers and creating a legacy. Where I come from, nobody is doing anything like this—building something of this scale, with this level of ambition, and bringing it to a global audience. That makes this achievement even more personal.
I’ve always aimed to inspire others, to show that no matter where you start, with the right vision and relentless determination, you can achieve the extraordinary. Taking XRP Healthcare public is a testament to that belief, a reflection of everything I’ve worked for, and a powerful reminder of what’s possible. I couldn’t be prouder of what we’ve accomplished—and I’m even more excited for what lies ahead
XRPH Press: How do you anticipate the announcement of going public will affect the value and market valuation of the XRPH token? What should token holders expect?
Kain: I’d rather not comment directly on price—that’s ultimately for the market to decide—but I would expect the announcement of going public to be viewed positively. This is a transformative milestone that signals growth, scalability, and a new level of legitimacy for XRP Healthcare.
This move could attract new investors, increase visibility, and create further confidence in the project’s long-term vision. It also demonstrates our commitment to transparency and accountability, which are critical for both market perception and token holders. For those holding XRPH, this is an opportunity to be part of something truly groundbreaking as we scale to even greater heights.
record to match our ambition. ARC Group stood out immediately because of their accomplishments— they’re not just any advisory firm; they’ve built a reputation for successfully taking companies public and delivering results time and time again.
What sealed the deal for me was ARC Group’s proven track record in taking companies public— including Trump Media via Digital World Acquisition Corp. (DWAC)—which speaks volumes about their expertise. When handling something as critical as a public listing, you need a partner with deep industry knowledge, strategic insight, and access to vital funding. With Abraham Cinta and ARC Group, we knew XRP Healthcare was in the right hands.
Their experience, combined with their ability to navigate complex financial landscapes, gave me the confidence that we were in the best hands. This isn’t just a business decision; it’s a monumental step forward for XRP Healthcare, and it was important to work with a firm that shared our vision and understood the significance of what we’re building. ARC Group was the ideal choice, and I couldn’t be more confident in what we’ll achieve together.
XRPH Press: With ARC Group’s statements about XRP Healthcare’s uniqueness and potential, what would you say to assure potential investors about the company’s long-term growth?
Kain: ARC Group is absolutely right in their assessment of XRP Healthcare’s uniqueness and potential. Their endorsement is a testament to the strength of our vision and the opportunity we’re addressing in the healthcare space. What we’re doing is tackling one of the most pressing challenges in the world today—the highly fragmented and underserved African healthcare sector.
XRPH Press: What was the process like in selecting ARC Group to spearhead the public listing? What qualities made them the right fit for this significant step?
Kain: The process of selecting ARC Group to lead our public listing was all about finding a partner with the right expertise, experience, and track
Africa’s healthcare market, valued at US $259 billion, is full of untapped potential but remains burdened by inefficiencies, limited access to quality care, and outdated systems. XRP Healthcare’s mission is to change that by creating a streamlined, consolidated approach that empowers private healthcare providers to scale and thrive. By focusing on mergers and acquisitions, we’re not just building a company—we’re building a legacy of improved care, better access, and a sustainable model for healthcare delivery.
What sets us apart is not just the opportunity we’re pursuing but the team we’ve assembled to make it happen. We have a dream team—a collective of highly talented and experienced individuals who are experts in their respective fields. From healthcare to business development and strategy, we’ve brought together the kind of expertise that ensures we’re making the right moves at every step.
To potential investors, I would say this: XRP Healthcare is not just another company—it’s a transformative force in an industry that’s long overdue for innovation. Our vision is ambitious, but our strategy is sound, our team is world-class, and the potential for long-term growth is undeniable.
XRPH Press: Are there any global precedents for a company like XRP Healthcare that combines blockchain, crypto, AI, and M&A within the healthcare sector? If not, what sets you apart?
Kain: To my knowledge, there are no direct global precedents for a company like XRP Healthcare that combines blockchain, cryptocurrency, AI, and mergers and acquisitions (M&A) within the healthcare sector. That’s precisely what makes us unique. We’re not following a blueprint—we’re creating one.
What sets us apart is the way we’re addressing real, tangible problems in the healthcare sector, particularly in highly fragmented markets like Africa. While there are companies leveraging blockchain or AI individually, or even conducting M&A in healthcare, no one is bringing these elements together in the way we are. By combining these advanced technologies with a strategic approach to scaling private healthcare through M&A, we’re creating an ecosystem that is both innovative and impactful.
Our vision is centered on improving access to quality healthcare, making it more affordable and efficient, especially in underserved regions. The integration of AI allows us to provide actionable insights and better decision-making, while blockchain ensures transparency, security, and efficiency in healthcare processes. And with M&A, we’re consolidating and scaling healthcare facilities to create a more unified and effective system.
I’ve always aimed to inspire others, to show that no matter where you start, with the right vision and relentless determination, you can achieve the extraordinary.
~ Kain Roomes, CEO of XRP Healthcare
At the core of it all is a deep understanding of the challenges within the sector and a commitment to delivering real-world solutions. We’re not just innovating for the sake of it—we’re innovating with purpose, and that’s what truly sets us apart. XRP Healthcare is charting a new course, and we’re proud to be leading the way.
XRPH Press: What can you share about the first acquisition by XRP Healthcare? How does it align with XRP Healthcare’s overarching goals?
Kain: Our first acquisition is an incredibly exciting milestone for XRP Healthcare and aligns perfectly with our mission to transform and consolidate private healthcare in Africa. The target company,
Pharma Ville Limited is a limited liability company specializing in the wholesale and retail distribution of pharmaceutical products in Uganda. The company is actively involved in importing and selling locally sourced pharmaceutical drugs and medical devices. Established in 2016, Pharma Ville Limited has since expanded its presence, operating through seven functional outlets across Uganda. These include three locations in Kampala and one each in Mbale, Mityana, Fort Portal, and Hoima districts.
With a strong focus on growth and market expansion, the company has successfully registered over 60 pharmaceutical products, with an additional 70 products currently in the pipeline. These products are strategically positioned within the pharmaceutical industry, offering significant potential to drive business performance. Among the registered products, 18 are ready for immediate commercialization, further strengthening Pharma Ville Limited’s market presence and enhancing its ability to meet the growing healthcare demands in Uganda.
This acquisition is particularly compelling due to its strong operational foundation and significant growth potential. With a robust pipeline of products, many ready for immediate commercialization, strategic investment from XRP Healthcare can drive performance to new heights.
Beyond growth, this move is about impact—scaling operations while enhancing healthcare accessibility for the communities that depend on these services. It marks a step toward building a more cohesive and efficient healthcare ecosystem across Uganda and beyond.
I see this acquisition as a cornerstone of our journey, one that demonstrates the kind of transformative change XRP Healthcare is committed to achieving. With the right investment and vision, this is just the beginning of what we can accomplish.
Kain: With this new acquisition, our primary goal over the course of this year is to enhance and modernize operations while maintaining continuity. One of our key initiatives is the refurbishment of pharmacies, ensuring they are upgraded to meet modern standards and provide an improved customer experience. Simultaneously, we will undertake a comprehensive rebranding under XRP Healthcare, aligning the business with our vision for growth and innovation.
In addition to these structural and brand enhancements, we recognize the value of the existing team and are committed to keeping them on board. Their expertise and familiarity with operations will be instrumental in ensuring a smooth transition and sustained success.
To facilitate these developments, all initiatives will be executed through our vehicle for going public, XRP Healthcare M&A Holding Inc., reinforcing our commitment to expansion and long-term sustainability in the healthcare sector.
XRPH Press: What strategic initiatives will be implemented to enhance operations and brand identity following the new acquisition?
XRPH Press: What is your key message to the XRP Healthcare community and potential investors as you embark on this next chapter?
Kain: To the XRP Healthcare community and potential investors: you are part of something groundbreaking. We are transforming healthcare, tackling a US $259 billion opportunity with vision, purpose, and a dream team committed to success. The progress we’ve made is just the beginning, and with each step forward, we’re proving that anything is possible. Now is the time to believe, to invest, and to join us as we make history together.
XRPH Press: What do you envision for the company’s growth trajectory in the next three years as it becomes a publicly traded entity?
Kain: In the next three years, we aim to position XRP Healthcare as a billion-dollar company. With strategic acquisitions, a clear vision, and a talented team driving innovation, we’re confident in achieving unicorn status and transforming the healthcare landscape in underserved regions.
Laban Roomes - COO of XRP Healthcare
XRPH Press: How has your experience been collaborating with your son on this groundbreaking venture? What lessons have you learned over the past two years?
Laban: Collaborating with Kain has been one of the most profound experiences of my life—not just as a father, but as a businessman. When you build a company with someone, trust is everything. When that person is your son, the trust is absolute. There is no second-guessing, no hidden agendas—just a shared vision and an unspoken intuition born of blood.
Together, we are not just building a business; we are building something bigger than ourselves—a lasting legacy that will stand the test of time.
His very existence is a testament to faith over fear. When his mother was three months pregnant, she contracted German measles. Doctors advised abortion, warning he’d likely be blind or deformed. But we knew—not just hoped or prayed, but knew— he would be fine. I was the one who cut his umbilical cord, lifted him to the sky, and saw him open his eyes. The first face he saw in this world was mine, and I knew from that moment he was destined for greatness.
Building XRP Healthcare with him has reinforced the lesson that the impossible is only impossible until it’s done. I grew up with my mother telling me that if I wanted to go to the moon, I would find a way, that’s how much she believed in me—and I believed her. That mindset shaped me, and now, it’s shaping this company. We don’t wait for opportunities; we create them.
doubters and trolls. Some dismissed us outright— not only because we were running a blockchain healthcare company, but because we were seen as two young Black men daring to lead in a space where few like us exist.
At first, the crypto community didn’t even believe we were father and son. Many assumed we were brothers, and there was an underlying bias—spoken or unspoken—that made it clear some people didn’t think we belonged. But here’s the thing about challenges: you can let them define you, or you can use them as fuel.
Every remark, every doubt, every negative comment became an opportunity to showcase our business, our self-worth, and our vision. We didn’t fight with words—we fought with execution.
XRPH Press: What has been the biggest challenge and the most rewarding aspect of achieving record milestones so quickly?
Laban: The greatest challenge has been entering a completely new sector. While we were early investors in crypto, running a company with its own token—let alone in healthcare and mergers & acquisitions— was uncharted territory for us both.
And if that wasn’t enough, we had to deal with the reality of perception. From the start, there were
And now we own seven pharmacy locations five wholesale, two retail. We are on the journey to becoming a public company. We have built a real business with real impact. That’s how you deal with doubt. You make it irrelevant.
XRPH Press: What does this transition mean for XRP Healthcare’s operations and scalability?
Laban: While we are on the journey to becoming publicly listed, we have been operating with the transparency of a public company since day one. Every token supply update, every key decision, every team member’s contribution—it’s all been shared openly. We have built trust not just with investors but with our growing global community. We are already operating at a level where compliance, reporting, and accountability are second nature. Going public is simply the next step in our inevitable expansion.
XRPH Press: How do you think going public will influence the sentiment around XRPH tokens and the company’s valuation?
Laban: Markets follow perception, and perception follows action. We are proving every day that XRPH isn’t just another token—it’s a real-world utility asset backed by tangible healthcare acquisitions. The anticipation of our public listing brings credibility. Our revenue-generating pharmacies add tangible value. Institutional capital will inevitably flow into
the ecosystem as we scale. This isn’t hype—it’s measurable progress.
XRPH Press: What role did you play in identifying and securing ARC Group as the partner for this monumental step?
Laban: My role was to see beyond the immediate— to find a partner not just for taking us public but for the long-term expansion of our business. ARC Group met that criterion.
Due diligence was critical—we needed a firm that understood the complexity of merging traditional finance with blockchain and healthcare. Negotiations were strategic—ensuring we align with a partner that is invested in our growth, not just the transaction. The decision was clear—ARC Group had the experience, network, and vision to take XRP Healthcare where we need to go. A successful partnership isn’t about who wants to work with you; it’s about who deserves to.
XRPH Press: What measures are in place to meet investor expectations post-public listing?
Laban: We are not waiting for the listing to prepare— we are already executing. Financial systems and governance are already in place. Acquisitions are strategically structured for sustainable expansion. AI-driven due diligence ensures every new acquisition adds value. Investors expect clarity, growth, and execution—we are delivering all three.
XRPH Press: How does XRP Healthcare’s model position it as a pioneer in the industry?
XRPH Press: What can you reveal about the first acquisition? How does it enhance XRP Healthcare’s strategy?
Laban: The acquisition of seven pharmacies in Uganda five wholesale, and two retail is proof of concept. Instant revenue streams with a 30 percent profit margin. A strategic foothold in a highdemand market. A platform for AI and blockchain integration into traditional healthcare. This is just the beginning—we now have the template to replicate and scale across Africa.
XRPH Press: What message do you have for the XRP Healthcare community and healthcare professionals as you enter this new phase?
Laban: We are doing what no one else is doing by seamlessly fusing blockchain, AI, and M&A into a healthcare powerhouse. Through blockchain, we ensure financial transparency by enabling seamless payments and verifiable transactions. Complementing this, AI drives diagnostics and operational efficiency, scaling healthcare access to unprecedented levels. Meanwhile, M&A fuels rapid expansion, transforming fragmented pharmacies into a cohesive, integrated healthcare network. This isn’t disruption for the sake of disruption—it is purposeful transformation, reshaping the future of healthcare.
Laban: To our community, investors, and healthcare professionals – We are not just a company; we are a movement. You’ve witnessed our transparency from day one. You’ve seen us execute milestone after milestone. Now, you will watch us redefine what’s possible in healthcare. Stay engaged. Stay invested. The best is yet to come.
XRPH Press: What strategic initiatives do you plan to implement post-public listing?
Laban: Expanding our acquisitions—we are targeting more pharmacies, medical centers, and healthcare licenses in key African markets. Scaling AI integration—strengthening our AI-powered chatbot for wider healthcare accessibility. Enhancing financial efficiency—optimizing inventory, logistics, and financial reporting to increase profitability. Driving investor and institutional adoption— educating markets on why XRP Healthcare is a category leader. Global expansion—beyond Uganda, we are eyeing high-impact markets to scale our healthcare model. This isn’t just business. This is legacy-building.
XRPH Press: Final thoughts?
Laban: Faith. Resilience. Execution. We don’t chase hype. We don’t wait for permission. We execute with precision. If you want to go to the moon—you can. You just have to build the rocket. And that’s exactly what we are doing.
XRP Healthcare Acquires Pharma Ville, a Retail and Wholesale Pharmacy Chain in Uganda
Founded in 2016 by experienced pharmacist Richard Kitonsa, Pharma Ville Ltd. has established itself as a prominent player in Uganda’s pharmaceutical sector. The company operates seven outlets: three in Kampala and one each in Mbale, Mityana, Fort Portal, and Hoima districts
Left to Right: Laban Roomes (COO & Co-Founder, XRP Healthcare), Richard Kitonsa (CEO & Founder, Pharma Ville Pharmacy Ltd.), and Kain Roomes (CEO, XRP Healthcare) at Pharma Ville Ltd.’s premises
XRP Healthcare, a pioneering force in healthcare innovation, has officially acquired Pharma Ville, a leading retail and wholesale pharmacy chain in Uganda. This strategic acquisition marks XRP Healthcare’s entry into Africa’s rapidly evolving healthcare sector, laying the foundation for scalable, technology-driven pharmaceutical distribution across the continent.
With two retail pharmacies and five wholesale distribution centres strategically positioned across Uganda, Pharma Ville’s established infrastructure enhances medicine accessibility nationwide. The acquisition strengthens XRP Healthcare’s ability to streamline pharmaceutical supply chains and expand its footprint in Africa’s healthcare market.
Shonubi Musoke & Co. Advocates, one of Uganda’s premier law firms and a partner of the globally renowned Norton Rose Fulbright, advised XRP Healthcare in this transaction, ensuring a seamless legal and regulatory transition.
Pharma Ville plays a pivotal role in Uganda’s healthcare sector, working closely with the National Medical Stores (NMS) and Joint Medical Stores (JMS) to ensure a steady and reliable supply of essential medicines. The acquisition includes 60 registered pharmaceutical products, 18 products ready for immediate commercialization, and 70 additional products in the pipeline awaiting regulatory approval.
Additionally, Pharma Ville has distribution agreements with eight global pharmaceutical suppliers, reinforcing its strong supply chain network:
• Toros Group (Switzerland) – Orthopedic supplies
Pharma Ville, emphasized the transformative impact of this acquisition: “Joining XRP Healthcare is transformative. We can now rapidly scale our operations, introduce innovative technologies, and better serve Uganda’s healthcare needs.”
Whitney Lynn, Chairman of XRP Healthcare, underscored the company’s mission: “Our goal is simple—make essential medicines more accessible and affordable. This acquisition is a major step toward achieving that.”
Kain Roomes, CEO of XRP Healthcare, highlighted the opportunity within Uganda’s healthcare sector: “Uganda’s fragmented pharmaceutical landscape presents immense potential. By integrating Pharma Ville, we can deliver immediate impact—improving access to essential medicines and optimizing healthcare delivery.”
• Ascensia Switzerland (Germany) – Diabetic care solutions
• Incepta Pharmaceuticals Ltd (Bangladesh) –Human drugs
• Amanta Health Care Limited (India) – Intravenous fluids
• Forans Latvia (Latvia) – Diabetic care products
• Mediteks (Turkey) – Surgical equipment
• Naari Pharma Pvt Limited (India) – Human drugs
• Universal Corporation Limited (Kenya) – Human drugs
Richard Kitonsa (MPS), Founder and CEO of
Laban Roomes, COO of XRP Healthcare, emphasized the groundwork laid for expansion: “We have spent significant time in Uganda developing the legal and operational frameworks necessary to scale this business rapidly. Our efforts will drive long-term improvements in healthcare accessibility.”
Pharma Ville will undergo immediate operational upgrades, including:
• Advanced inventory management to optimize supply chains
• Upgraded licensing to expand product offerings
• Enhanced distribution channels for wider reach
• Digital payment integration for seamless transactions
• New CRM systems to improve customer engagement
By Q4, Pharma Ville will rebrand as XRP Healthcare, aligning with the company’s vision for innovation and healthcare excellence.
The XRPH AI app, a multilingual healthcare assistant, is already live and integrated into Pharma Ville’s digital platform (www.pharmaville.ai). The AI-driven tool provides medical guidance in Luganda, Swahili, Kinyarwanda, French, and English. In an upcoming update, users will be able to upload images of medical conditions for AI-assisted preliminary
assessments, with direct referrals to healthcare professionals for critical cases.
Peter Waiswa, a strategic advisor to UNICEF, the Bill & Melinda Gates Foundation, and now XRP Healthcare, praised the acquisition’s significance:
“This acquisition strengthens Uganda’s healthcare sector, fosters economic growth, and introduces essential technologies to the industry. It’s a major step forward for healthcare accessibility in Uganda.” With Africa’s healthcare market projected to reach US $259 billion by 2030, and the digital health segment—encompassing AI-driven solutions— expected to grow to US $16.6 billion, XRP Healthcare
is strategically positioned to capitalize on these transformative opportunities.
XRP Healthcare holds registered trademarks in Uganda, the UAE, the UK, and the 27 EU countries, reinforcing its commitment to innovation and brand excellence.
Additionally, XRP Healthcare has informed its community of an upcoming global announcement, separate from its African expansion, to be revealed this quarter. This development reflects the company’s broader strategic ambitions and commitment to advancing global healthcare solutions.
Left to right: Kain Roomes, CEO of XRP Healthcare, and Richard Kitonsa, CEO and Founder of Pharma Ville Pharmacy Ltd., during the signing of the acquisition agreement at Shonubi, Musoke & Co. Advocates
Left to Right: Kain Roomes (CEO, XRP Healthcare), Richard Kitonsa (CEO & Founder, Pharma Ville Pharmacy Ltd.), and Laban Roomes (COO & Co-Founder, XRP Healthcare), inside the newly acquired facility
ACQUISITION
Scaling Access Through Pharma Ville
Through our acquisition of Pharma Ville, a leading pharmacy chain in Uganda, XRP Healthcare has expanded its global network through strategic partnerships to improve healthcare access across Africa.
With a pharmacy network in place, our partnerships with global pharmaceutical leaders will have a direct, on-the-ground impact, ensuring that lifesaving medications reach those who need them quickly and efficiently.
Powerful Partnerships Driving Change
A robust supply chain is key to sustainable healthcare. That’s why we’ve partnered with global leaders in pharmaceuticals, diagnostics, and medical supplies to make high-quality healthcare a reality for millions. Each of these collaborations addresses a critical healthcare need in Africa:
• Incepta Pharmaceuticals (Global leader in generics & biotech): Across Africa, millions struggle to access essential medications due to high costs and supply shortages. Incepta Pharmaceuticals is changing that by providing affordable, high-quality generic medicines and biotechnological innovations. This partnership ensures patients receive effective treatment options without financial burden.
• Naari Women (Reproductive & hormone therapy): In many parts of Africa, access to reproductive healthcare remains a challenge. Women face barriers to hormone therapy,
contraception, and essential treatments. Through our partnership with Naari Women, we’re ensuring that every woman receives the care she deserves, empowering them with lifesaving medications and reproductive health solutions.
• Ascensia Diabetes Care (Diabetes monitoring & treatment): For millions in Africa, diabetes goes undiagnosed until it’s too late. Without early detection, complications arise, leading to severe health consequences. Our partnership with Ascensia Diabetes Care is transforming diabetes management by introducing cutting-edge glucose monitoring technology. By providing patients with real-time monitoring solutions, we enable early intervention, better treatment outcomes, and healthier futures.
• Medrull Medical Products (Wound care & first aid): A simple wound can turn deadly without proper care. Across Africa, access to quality wound care and first aid supplies is often limited. Through Medrull Medical Products, we’re strengthening medical supply chains to ensure hospitals, clinics, and emergency responders have access to high-quality wound care solutions, reducing infection risks and saving lives.
• Toros Group (Pharmaceutical manufacturing & distribution): The demand for life-saving medicines continues to rise, yet supply bottlenecks persist. That’s why we’ve partnered with Toros Group, a powerhouse in pharmaceutical manufacturing and global distribution. This collaboration enhances our ability to distribute essential medications at scale, making treatments more accessible and affordable.
• Universal Corporation Ltd (African pharma leader): Local expertise is crucial for sustainable healthcare transformation. As we expand
into Africa, we recognize the importance of partnering with trusted, homegrown leaders. Universal Corporation Ltd, a leading African pharmaceutical company, specializes in essential medicines and regulatory compliance. Together, we’re bringing high-quality, affordable healthcare solutions tailored to the continent’s unique needs.
• Amanta Healthcare Ltd (Injectables & critical care medicines): In critical care, every second counts. High-quality injectables and sterile solutions are essential for hospitals and emergency treatments. That’s why we’ve joined forces with Amanta Healthcare Ltd, a global leader in injectables and life-saving medicines. Our partnership ensures that patients receive safe, reliable, and effective treatments when they need them most.
Pharma Ville plays a pivotal role in Uganda’s healthcare sector, working closely with the National Medical Stores (NMS) and Joint Medical Stores (JMS) to ensure a steady and reliable supply of essential medicines.
Abraham Cinta- CEO ARC Group
Abraham Cinta: ARC Group CEO Steering XRP Healthcare’s Public Listing
BY BENJAMIN OPUKO
Abraham Cinta, CEO and founder of ARC Group, has built a global financial advisory powerhouse connecting businesses across Asia, the U.S., and Europe. Raised in Mexico, Cinta pursued higher education in the U.S. and the UK, earning a master’s in investment banking from the University of Wales during the 2011-2013 financial crisis. Facing a challenging job market, he moved to Asia, securing a three-month internship in China that evolved into a transformative 13-year career.
Fascinated by China’s opportunities, Cinta joined a boutique investment bank specializing in U.S.China cross-border deals. In 2014, he co-founded ARC Group, initially focusing on small capital market transactions between the two regions. Over the past decade, ARC Group has expanded into a global financial advisory firm with a presence in 14
countries, helping mid-market companies navigate international markets.
Cinta attributes ARC Group’s success to its proximity to clients, operating in key emerging markets like Delhi, Jakarta, and Ho Chi Minh. Under his leadership, ARC Group has become a trusted partner in crossborder finance. In a recent discussion, Cinta shared insights into his role in XRP Healthcare’s public listing, his entrepreneurial journey, the firm’s evolution
Taking XRP Healthcare public
XRP Healthcare is on the verge of a major transformation as it prepares to go public, a move that has the potential to fast-track the company’s growth and open new doors in the global healthcare market. The partnership with ARC Group, a key player in the deal, is expected to play a pivotal role in XRP’s expansion, especially into new and untapped markets.
“What excites us the most about XRP Healthcare, particularly from ARC’s perspective, is the geographic coverage,” Cinta remarked. He explained that XRP Healthcare’s focus on markets that ARC has explored in the past but hasn’t been highly active in is a key factor driving the excitement. The partnership, he believes, presents a unique opportunity to establish a stronger presence in these emerging markets.
For ARC, breaking into these regions and successfully expanding is not just a strategic move—it’s a milestone they are eager to achieve. “Successfully breaking into these markets would be a significant achievement for us,” Cinta stated.
On the other hand, the decision for XRP Healthcare to go public holds immense promise for the
From left to right: COO Carlos López, CEO Abraham Cinta, and President Sergio Camarero
company. “Going public through a structured vehicle could dramatically accelerate its progress,” Cinta noted. With a business model that stands out in the healthcare sector, XRP has the potential to expand rapidly. According to Cinta, the company’s robust capabilities and innovative approach make it well-positioned to benefit from the increased transparency and visibility that comes with being publicly listed.
A public listing could expose XRP to a broader pool of investors, who will be able to track the company’s progress and financial health more closely. This visibility, Cinta believes, is a crucial factor in drawing attention to XRP Healthcare’s unique approach to healthcare. “The spotlight of being a public company is immense, and it could transform their business exponentially, perhaps by a factor of 10 or even 100,” he shared, reflecting on the massive growth potential that the public offering could unlock.
Cinta’s confidence in the partnership is steadfast. He highlighted the importance of the team at XRP Healthcare, stating that they already possess the right mix of talent, spirit, and ambition. With the added backing of ARC Group’s expertise, this partnership is poised to provide the final piece needed to accelerate XRP Healthcare’s plans for growth. “With the right structure, we are confident this could become a multi-billion-dollar business,” Cinta affirmed.
ARC Group’s adaptability has been key to its success. Over the past decade, the firm has navigated an evolving market landscape marked by the emergence of blockchain, artificial intelligence, SPACs, and geopolitical shifts. According to Cinta, these changes didn’t signal flaws in the original vision but rather the necessity to “adjust to the market.”
Looking ahead, Cinta envisions a decade of significant growth for ARC Group. “The first 10 years have been about building the foundation of our business. The next 10 should be about really taking off,” he stated. He dreams of expanding further into underserved markets like Africa and the Middle East, regions he believes hold immense potential. “Our goal is to continue being the best at what we do, ensuring that everyone knows who we are and what we stand for—excellence, quality, and success,” he affirmed.
Empowering leadership at ARC Group Abraham Cinta’s leadership philosophy has been instrumental in shaping ARC Group’s success. When asked about his leadership principles, he humbly deflected the focus to his team, saying, “That’s always a tough question—I think it’s better answered by those who work with me. But I believe in opportunities and empowering people. At the end of the day, if you want to go fast, you go alone. But if you want to go far, you need a team.”
The vision and evolution
“When you think about it, it’s funny—but I suppose that’s destiny,” Abraham Cinta remarked as he reflected on ARC Group’s upcoming milestone. The firm’s trajectory over the past 10 years has been shaped by a steadfast commitment to its original vision while adapting to the ever-changing global financial landscape.
“Looking back to 10 years ago, the vision we had at that time and where ARC Group is today as one of the go-to financial advisory providers, I wouldn’t say the vision has changed drastically,” Cinta shared. “However, I wouldn’t be doing my job well if I said I was completely satisfied with where we are—there’s always room to achieve more.”
Cinta has cultivated a unique culture at ARC Group, positioning the firm as a platform where individuals can achieve their full potential. “We don’t operate with a rigid hierarchy or structure within the firm,” he explained. “In many large organizations, employees often have narrowly defined roles and titles. Their contributions are limited by those roles, and they’re expected to stick strictly to what the job description says. I don’t believe in that model.”
By fostering an environment of empowerment and opportunity, ARC Group has been able to attract and retain highly capable individuals who drive the company’s growth. “It can be challenging to implement this mindset in today’s world because many people seek recognition and titles, and those things often serve as motivators. But I’ve found that
by focusing on empowering people and providing opportunities, you create an environment where those who succeed will naturally elevate both themselves and the company,” Cinta said.
Milestones and challenges
Building a reputation in a competitive industry dominated by giants like Barclays, Citibank, and Goldman Sachs is no small feat. “One of the biggest challenges for any small business—just as we were 10 years ago—is competing with the larger, more established brands,” Cinta explained. Unlike established firms with extensive resources and infrastructure, ARC Group started with a lean team and a bold vision.
A turning point came two years ago when ARC Group began appearing in league tables alongside these financial powerhouses. “Our name started showing up alongside those big brands—Barclays, Citibank, Goldman Sachs—even if it was in a specific niche of the market,” Cinta noted. This achievement was not just symbolic but transformative, signaling to clients and competitors alike that ARC Group had arrived as a serious contender.
Since that pivotal moment, ARC Group has maintained an upward trajectory, leveraging its expertise to bridge the economic corridors of Asia, the U.S., and Europe. Under Cinta’s leadership, the firm has continued to excel, offering tailored financial advisory services that address the unique needs of its diverse client base. “Despite the challenges and changes along the way, the core vision has remained intact,” Cinta affirmed.
a solid foundation, but the real challenge lies in ensuring the company’s longevity and sustainable growth.
Cinta pointed to the statistic that only a small percentage of businesses survive their first five years. ARC has not only surpassed that threshold but has doubled it, laying the groundwork for the next phase of growth. “To stay for another 10, 20, or even 30 years, we have to keep strengthening our position as the go-to bank for anything cross-border,” he emphasized.
Looking ahead, Cinta envisions a future where ARC Group has expanded its global presence significantly. “If I were to dream big, I’d love for us to have one, two, or three offices in every single country we currently operate in,” he said, outlining his goal to cement ARC’s reputation in each market. Beyond that, he is particularly excited about the potential to grow further into underserved regions like Africa and the Middle East. “If we can do a good job in those regions, it could really propel the future of ARC,” he added, recognizing the untapped opportunities these markets represent.
Over the next decade, Cinta’s focus will be on maintaining excellence and continuing to elevate ARC Group’s brand recognition globally. “Our focus should be on continuing to excel, ensuring everyone knows who we are, what we do, and associating our name with excellence, quality, and all the attributes needed for success,” he noted.
Advice for aspiring entrepreneurs
ARC Group’s next decade of growth and expansion As ARC Group celebrates a decade of success, Abraham Cinta looks ahead with a clear vision for the future. Reflecting on the company’s journey, Cinta emphasizes that the next ten years will be crucial in transforming ARC into a dominant player in cross-border finance and expanding its footprint into new, underserved markets.
When asked about ARC Group’s future outlook, Cinta was quick to highlight the importance of the journey over the destination. “It’s never enough. It’s always about the journey, not the destination,” he remarked. The first ten years, he explained, were about building
For those looking to follow in his footsteps, Cinta highlighted resilience as a key quality. “The market changes every day, and being able to stay on track and stick to your convictions is critical,” he advised. He also emphasized the importance of surrounding oneself with the right team. “The core team that started ARC is still with us after 10 years. Many competitors have come and gone, often because they lacked the right partnerships,” he noted.
As for pitfalls to avoid, Cinta cautioned against overspending and poor financial decisions, urging entrepreneurs to treat capital as a precious resource. “If you stay resilient, stick to your convictions, and build the right team, success will follow,” he concluded.
Timing, Strategy, and Vision: Andrew Bell on Preparing Companies for Public Markets
BY BENJAMIN OPUKO
Going public is a transformative milestone for any company, but what does it take to get there? Andrew Bell, Director and Chief Investment Officer (CIO) of ARC Group, shares his insights into the key considerations for businesses eyeing a public listing. From crafting a compelling story to mastering the art of timing, Bell highlights the nuanced journey companies must undertake.
From accountancy to strategic leadership
Bell’s foray into the professional world began in 2008 as a trainee accountant, a career choice influenced by his father. “Accountancy provided me with a solid foundation in auditing, taxation, and a deeper understanding of business and global economies,” Bell explained. His early focus on audit laid the groundwork for co-founding a new practice in 2012, but he soon found the UK’s economic environment stifling.
Dubai in 2017, where he transitioned from traditional finance roles to innovative ventures.
Bell’s tenure at Beehive, a fintech startup and the MENA region’s first regulated peer-to-peer lending platform, stands out as a transformative period. Under his leadership, the company grew its revenue tenfold, achieved cashflow-positive status, and ultimately sold to Etisalat. This success set the stage for his pivotal role at ARC Group.
The power of a resonant story
The decision to go public, according to Bell, is not one-size-fits-all. “The type of business and its goals will determine if it’s the right time to go public,” he explained. Whether it’s a startup with a unique plan or a more traditional enterprise aiming to accelerate growth, the timing and strategy must align with the company’s objectives.
“Ultimately, it’s about whether the market will resonate with the company’s story,” Bell explained. For him, the narrative a company crafts is pivotal. It’s not just about the numbers; it’s about showing the market a vision that is both believable and executable.
“The rising cost of living, shrinking opportunities, and competition from big firms like PwC and KPMG made the accountancy field increasingly challenging,” Bell reflected. These factors prompted his move to
“Are you telling a story that people will believe, and one that you can execute?” Bell asked rhetorically. For many companies, this means articulating a clear and achievable plan, whether it’s expanding operations, revamping management, or pursuing an acquisition.
Timing is everything
Bell stressed the importance of timing when entering the public markets. “You need to deliver on your promises and reach milestones, even if those milestones aren’t heavy growth or strong profits right away,” he noted. Success in the public sphere often depends on consistently demonstrating progress toward stated goals, whether through financial growth, operational efficiencies, or strategic pivots. The process, Bell pointed out, is gradual. Companies must show the market they can follow through on their commitments over time.
Andrew Bell - Director & CIO of ARC Group
Leveraging public markets for high-stakes industries Bell cited the biotech industry as a prime example of how public markets can be leveraged to fuel innovation. “Take biotech, for example. Many biotech companies, especially those developing cancer treatments, need significant funding to go through clinical trials and FDA approval processes. They list early to raise capital and execute their plans.”
While acknowledging the inherent risks—such as potential drug failures or even delisting—Bell emphasized that the public markets provide an unparalleled advantage: continuous access to funding. This liquidity is particularly valuable for industries requiring long-term investment to bring innovations to market.
Bell also drew a contrast between private and public markets. He described the private market as increasingly challenging, especially post-COVID-19. “Valuations are lower, and liquidity is limited,” he said. Public markets, on the other hand, offer constant liquidity and a broader pool of investors.
“Public markets provide constant liquidity, with more buyers than sellers,” Bell remarked. This liquidity makes it easier for companies to raise funds, regardless of their revenue status or growth stage. From startups to mature enterprises, the public market offers a dynamic platform for securing capital and driving expansion.
Advice for startups: Focus on the exit strategy
and establishing corporate governance that meets both listing and post-listing standards, going public could be a strong option,” Bell advises.
An IPO not only provides access to capital but also offers investors a clear timeline for potential returns. “If they invest now, they could potentially see a return in three to four years, which makes them more willing to back you from the start.”
Execution is key: Challenges beyond listing
The journey of a business doesn’t end once it goes public; in many ways, it’s just the beginning. Andrew Bell, a seasoned expert at ARC Group, sheds light on the critical factors that influence a company’s success after its initial listing. According to Bell, the most challenging phase for businesses often comes after the initial public offering (IPO). “As advisors, we can help businesses get listed, but executing the plan and managing the share price post-listing is ultimately up to the business owners,” Bell emphasizes. He underscores the importance of sticking to the plan and managing shares thoughtfully, noting that erratic share price movements can deter investor confidence.
When asked about the most critical advice for startups looking to go public, Bell stresses the importance of planning for investor returns. “For a startup, particularly in a sector like fintech, my advice would be to focus on the exit strategy from day one,” he says.
“Investors are ultimately looking for a return on their investment,” Bell adds. “The more you can de-risk that for them and give them a clear liquidity event— whether it’s a successful Series B or C, or an IPO—the better.”
For startups, considering an IPO as an alternative to late-stage funding rounds can be a smart move. “If you’re hitting milestones, maturing as a business,
A successful post-listing strategy hinges on meeting market expectations. “A company might have the best plan and team in the world, but if they can’t meet the goals and ambitions they’ve communicated to the market, the stock will struggle,” Bell explains. He stresses that while ARC Group provides valuable advice, the ultimate responsibility for operational success lies with the business itself.
Comprehensive post-listing services
Despite the inherent challenges, ARC Group extends a suite of post-listing services to support businesses in their growth journey. Bell elaborates, “We provide a variety of services post-listing, including financial services for filings and regulatory compliance. We can also assist with funding rounds, such as private investment in public equity (PIPE), new share issuances, and secondary sales of shares.”
These services, Bell explains, are designed to ease the administrative and strategic burden on business owners, enabling them to focus on execution. ARC Group also assists in business development
initiatives such as acquisitions, market expansions, and capital raises.
Holistic support across business stages
Bell highlights ARC Group’s multifaceted approach to supporting companies at various stages of their lifecycle. “We offer a broad spectrum of services across different stages and verticals within ARC, including consulting, wealth management, fund administration, M&A activities, and capital markets,” he notes. This comprehensive framework ensures that businesses have access to the resources and expertise they need to navigate the complexities of being a public entity.
While ARC Group plays a pivotal role in guiding businesses, Bell reiterates that the core responsibility remains with the company. “We can offer advice and a range of services, but once a business is listed, the responsibility is theirs,” he states. This balance of guidance and accountability is crucial for companies aiming to achieve sustainable success in the public market.
Market recovery analysis
As global markets emerge from a period of prolonged turbulence, Andrew Bell, an expert in market dynamics and financial strategy, predicts a vibrant and transformative era ahead. With 2025 on the horizon, Bell’s insights offer a hopeful glimpse into the future of global business, shaped by innovation, competition, and strategic regulation.
Global competition driving innovation
Bell elaborated on the importance of global competition as a catalyst for growth. “The competition forces companies to innovate and refine their strategies,” he explained. “It’s not just about survival; it’s about positioning yourself as a leader in your industry. Markets that embrace this will thrive, and the businesses operating within them will benefit immensely.”
This perspective highlights how competition can stimulate innovation, encouraging businesses to adopt new technologies, optimize operations, and seize emerging opportunities. According to Bell, the interplay of competition and innovation will be instrumental in shaping the success of global markets in the coming years.
The role of regulation in
market growth
Addressing the regulatory landscape, Bell emphasized the delicate balance that policymakers must achieve to foster growth without stifling innovation. “I also think regulators will need to reassess whether their regulations are truly probusiness,” he noted. “Their job is to strike a balance: not to stifle the market, but to manage risk for investors while fostering growth.”
Reflecting on the current market trajectory, Bell highlighted the resilience of global markets and their potential for recovery. “Looking ahead to 2025, I think it’s going to be an interesting year. The markets have been subdued for the last couple of years, but with the geopolitical situation in the US and Europe working to attract businesses back—such as the London Stock Exchange—I believe there will be a lot of competition globally, which is great for businesses,” he shared.
This optimistic outlook underscores the critical role of geopolitical shifts in revitalizing major financial hubs. Bell’s remarks suggest that as nations adapt to changing economic landscapes, businesses are poised to benefit from an increasingly interconnected and competitive environment.
He added that forward-thinking regulation could significantly impact how quickly markets rebound and expand. “We need a regulatory environment that supports innovation while protecting stakeholders. It’s a challenging but necessary equilibrium,” he explained. Bell’s call for balanced regulation underscores its potential to create a stable yet dynamic market environment conducive to sustainable growth.
Navigating market dynamics
Bell’s expertise extends to interpreting market trends and their implications for global business. Reflecting on regulatory differences between the U.S. and China in cryptocurrency, he highlighted the potential of regulated crypto markets. “Regulated cryptocurrencies can clean up the market, attract institutional investors, and provide emerging markets with stable transaction solutions,” he said.
Brandon Goodwin: Seeking first to understand to deliver bespoke solutions
BY HELLEN MUCHERU
A visionary leader in global finance
Brandon Goodwin’s leadership at ARC Group represents a masterful blend of vision, innovation, and empathy. By bridging global markets, championing technological advancements, and fostering client success, he has positioned ARC Group as a trailblazer in the competitive financial advisory landscape.
From navigating complex challenges to embracing emerging trends in healthcare and artificial intelligence, Brandon’s forward-thinking approach ensures that ARC Group remains at the forefront of industry transformation. Businesses seeking a trusted partner to navigate the complexities of global finance will find in ARC Group not just solutions but a visionary pathway to enduring success under Brandon’s inspiring leadership.
resilience in today’s volatile financial environment. He also expressed a measured optimism about the potential implications of Donald Trump’s re-election on global markets, highlighting opportunities for growth and investment.
In a recent conversation, Brandon shared valuable insights into his career trajectory, the distinguishing factors of ARC Group, and his outlook on the global economic landscape. Reflecting on the firm’s mission, he emphasized the importance of adaptability and
Client-centric philosophy
As the Vice President for the Middle East at ARC Group, Brandon leverages a wealth of international experience and a forward-thinking approach to redefine the landscape of financial advisory services. His leadership has been instrumental in expanding ARC Group’s footprint across markets, fostering strategic connections, and driving transformative transactions.
Brandon’s professional journey is as remarkable as it is inspiring. Hailing from Ireland, his career has taken him across continents—from Australia to London, and now to Dubai. Over a decade in investment banking, he has cultivated a deep expertise in capital markets, mergers and acquisitions, and corporate strategy. Yet, what truly sets Brandon apart is his firm commitment to a client-centric
Brandon Goodwin - ARC Group Vice President - Middle East
Brandon Goodwin
Vice President - Middle East Arc Group
Brandon Goodwin serves as the Vice President for the Middle East at ARC Group, bringing extensive leadership experience across both private and public capital markets. Before joining ARC Group, he held the role of Managing Director at a century-old financial services firm and Market Maker on the New York Stock Exchange. In this capacity, he spearheaded global business development and client relationship initiatives, driving the firm’s strategic growth. With a proven track record in capital markets and international business, Mr. Goodwin continues to play a pivotal role in connecting regional companies to global financial opportunities.
philosophy. At the heart of his approach lies a guiding principle: “Seek first to understand, then to be understood.” This mantra highlights his dedication to deeply comprehending client needs and delivering bespoke solutions that align with their goals.
Under Brandon’s stewardship, ARC Group has emerged as a leader in the financial advisory space. The firm’s innovative strategies and global perspective have enabled it to navigate complex financial landscapes with agility and precision. By bridging diverse markets and fostering cross-border collaborations, ARC Group continues to create value for its clients and stakeholders alike.
Boutique values with global ambitions
Under Brandon’s leadership, ARC Group has successfully blended the personal touch of a boutique firm with the expansive capabilities of a global financial powerhouse. This unique duality
defines ARC’s approach, prioritizing accessibility, innovation, and a steadfast commitment to client
Despite its global presence, ARC Group maintains an ethos of close-knit communication and adaptability. Brandon emphasizes the firm’s “whatever it takes” mindset, which drives its success to completing even the most challenging mid-market transactions. With offices across Asia, the United States, Europe, and the Gulf Cooperation Council (GCC), ARC operates seamlessly across geographies,
Leveraging local expertise while bridging cultural and “Aligning people and creating win-win scenarios is at the heart of what we do,” Brandon shares, emphasizing ARC Group’s core philosophy. This approach is fundamental to the firm’s role as a conduit for international collaboration and growth. By fostering strong partnerships and understanding the needs of both local and international stakeholders, ARC Group facilitates seamless cross-border capital market transactions.
Through this, the firm ensures mutual benefit for all parties involved, enabling companies to expand globally and access new financial opportunities. As a result, ARC Group plays a pivotal role in bridging markets and driving economic progress on a global scale.
Helping Middle Eastern companies list on global financial systems
The Middle East represents a cornerstone of ARC Group’s growth strategy under Brandon’s leadership. Over the past two years, the firm has solidified its presence in the region, serving as a vital
bridge between Middle Eastern companies and international markets, particularly in the U.S. and Canada. Brandon envisions expanding ARC Group’s wealth management platform and increasing assets under management (AUM). A key focus lies in guiding Middle Eastern companies toward U.S. public listings on platforms such as NASDAQ, showcasing the transformative potential of these markets. “We aim to show local companies that listing on U.S. markets can be a game-changer,” Brandon states.
Brandon’s insights into the region’s financial markets highlight the importance of creating tailored solutions that reflect the unique needs of Middle Eastern businesses. By leveraging its extensive expertise, ARC Group has become a trusted partner in navigating the complex regulatory landscapes and capital requirements associated with crossborder transactions. This approach not only accelerates growth for regional firms but also fosters greater integration of Middle Eastern economies into the global financial system.
urgency for investors to understand and embrace AI’s transformative potential.
The numbers speak for themselves. According to McKinsey (2023), AI could contribute a staggering US $25.6 trillion to the global economy in the coming years. In 2023 alone, the global AI market was valued at nearly US $208 billion, and projections from Statista (2023) estimate it will soar to US $2 trillion by 2030.
These figures underscore not only AI’s immense growth potential but also its disruptive power in reshaping investment landscapes. For investors, understanding AI’s implications is no longer optional; it is essential for navigating and capitalizing on the rapidly evolving financial markets.
Advice for companies aspiring to go public
Brandon’s optimism is further fueled by Donald Trump’s re-election as the U.S. president, which he views as a catalyst for continued economic growth. Citing Trump’s historical impact on capital markets, he notes, “Trump’s administration has consistently instilled stability and confidence in the financial sector,” pointing to the surge in stock markets and the rise in private equity valuations during his tenure.
For ARC Group, this presents a unique opportunity to capitalize on cross-border ventures, particularly in bridging the Middle East and U.S. markets through public offerings and strategic partnerships. With Trump’s re-election, Brandon believes the environment could become even more favorable, further fueling global financial growth and reinforcing ARC Group’s leadership in international financial advisory.
Embracing innovation and market trends
Artificial intelligence is a central theme in Brandon’s outlook on the future of finance. He views AI as a transformative force, reshaping industries by driving efficiency and fostering innovation. “AI is on the tip of everyone’s tongue and is set to drive growth for decades,” Brandon observes. His insights reflect the
Brandon offers sage advice for companies aspiring to go public: “Start early. Operate your business as if it’s already public from day one.” This proactive approach—ensuring robust audits, financials, and corporate governance—lays the groundwork for seamless transitions into public markets.
For businesses navigating complex processes such as mergers, acquisitions, and initial public offerings, engaging trusted advisors like ARC Group can be a game-changer. With its deep expertise and strategic guidance, ARC Group empowers clients to achieve their ambitions with confidence and clarity.
Brandon envisions expanding ARC Group’s wealth management platform and increasing assets under management (AUM). A key focus lies in guiding Middle Eastern companies toward U.S. public listings on platforms such as NASDAQ. We aim to show local companies that listing on U.S. markets can be a game-changer.
Charles Chong’s Capital Markets Playbook: Mastering Preparation, Timing, and Execution for Unmatched Success
BY HELLEN MUCHERU
Charles Chong – Vice President of Operations, EMEA
The capital markets industry is fast-paced and demanding, requiring expertise, precision, and strategic execution. Charles Chong, Vice President of EMEA Capital Markets at ARC Group, is a seasoned investment banker specializing in complex financial transactions like Reverse Takeovers (RTOs), Initial Public Offerings (IPOs), and Special Purpose Acquisition Companies (SPACs). With experience across major stock exchanges such as NASDAQ, NYSE, TSX, and international hubs like Dubai’s DFM and ADX, he is a respected expert in global capital markets.
Chong’s career began at KPMG as a consultant in governance practices before moving to Ernst & Young (EY), where he advised multinational companies and worked closely with government offices, including national development plans. These experiences sharpened his ability to manage complex financial transactions. In a recent discussion, he shared insights on preparation, timing, and execution—key factors in navigating the competitive world of capital markets.
The trifecta that underpins success in the competitive capital markets
i. Preparation: Building the foundation for success Preparation is the critical first step in ensuring a company’s journey to the capital markets is both smooth and successful, laying the groundwork for investor confidence and long-term growth. “Companies need a strong growth story that resonates with investors,” Chong explained, emphasizing the importance of solid financials and strict adherence to regulatory requirements. A compelling narrative not only attracts investor confidence but also differentiates a company in a crowded marketplace.
Colleagues describe Chong as the “technically experienced guy,” highlighting his deep knowledge and hands-on approach. At ARC Group, he focuses on seamless financial strategies, ensuring companies like XRP Healthcare are well-prepared for public listing. He emphasizes that success in capital markets requires technical expertise, strong governance, and effective stakeholder management.
Preparation extends beyond the company itself to include meticulous planning with all involved parties. From the client and shell company to service providers and the exchange, every stakeholder must be aligned on the goals and strategy. This foundational groundwork ensures a seamless progression through the transaction process.
One of the critical aspects of preparing for a public listing is developing a compelling narrative that captures the company’s vision and potential. Chong highlighted that for XRP Healthcare, this meant presenting their growth story in a way that would appeal to investors in both the healthcare and blockchain sectors.
“Preparation is key. Building a strong foundation within the team is crucial for the process to run smoothly,” Chong emphasized. This involves not only aligning the leadership team but also ensuring
that all compliance and regulatory requirements are met. By prioritizing transparency and rigor, ARC Group ensures that XRP Healthcare enters the public market with a solid footing.
ii. Timing: Leveraging market dynamics
Timing, Chong highlighted, is a pivotal factor in determining the success of transactions. “Aligning with favorable market conditions can make a significant difference in the outcome,” he noted. Market dynamics, investor sentiment, and geopolitical factors all influence the optimal window for listing a company
Chong stressed the importance of agility and adaptability, as market conditions can shift rapidly. Successful teams monitor these changes closely and are prepared to pivot strategies if necessary. This proactive approach enables companies to capitalize on opportunities and mitigate risks associated with timing missteps.
iii. Execution: The art of orchestrating success
Flawless execution, Chong remarked, is where all the groundwork comes to fruition. This phase involves managing a complex web of moving parts, including due diligence, regulatory approvals, and stakeholder coordination. Clear communication plays a critical role here.
approach to communication is a hallmark of his leadership style.
Guiding XRP Healthcare’s “going public” journey
The journey to becoming a publicly listed company is one of the most significant milestones for any organization. For XRP Healthcare, this journey has been marked by meticulous preparation, expert guidance, and a clear vision for the future, ensuring it is positioned for success.
Before any company steps into the public markets, Chong emphasized the importance of comprehensive due diligence. “At ARC Group, we have a readiness test to ensure thorough due diligence,” he explained. This involves a detailed assessment of the company’s financial health, governance structures, and market positioning. By identifying strengths and addressing potential gaps early in the process, ARC Group sets the stage for a successful listing.
For XRP Healthcare, this readiness test was instrumental in crafting their story for investors. Chong shared that, “We understand what investors are looking for, so we work on developing an investor deck and ensuring the company’s narrative resonates with the market.” This investor-focused approach ensures that XRP Healthcare’s value proposition is communicated effectively, building confidence among stakeholders.
“You’re dealing with multiple stakeholders, including the client, the shell (in the case of an RTO), service providers, and the exchange itself. It’s vital to ensure everyone is on the same page,” Chong stated. This transparency fosters trust and alignment, creating an environment where challenges are addressed swiftly and collaboratively.
Throughout the discussion, Chong repeatedly emphasized the centrality of communication. “Clear communication is key throughout the process,” he said, underscoring its role in building trust and ensuring alignment among stakeholders. Miscommunication, he warned, can derail even the most meticulously planned transactions.
By fostering open lines of communication, Chong ensures that all parties remain informed and engaged, minimizing the potential for misunderstandings and delays. This disciplined
From TSX-V to the U.S.: A strategic vision for the future
While XRP Healthcare is preparing to list on the TSX Venture Exchange (TSX-V), this is just the beginning of a broader vision. According to Chong, the ultimate goal is to have the company listed in the United States within five years.
“We’ve had discussions with the team, and we believe that listing on TSX-V is just one of many steps toward that goal,” Chong shared. This strategic approach positions XRP Healthcare to expand its investor base and achieve greater visibility in global markets.
By leveraging the experience gained from the initial listing, the company can build momentum for future milestones, including a potential listing on major U.S. exchanges like NASDAQ or NYSE.
For Charles Chong and ARC Group, the focus is not only on achieving a successful listing but also on positioning XRP Healthcare for sustained growth post-listing. The process is as much about preparation as it is about execution. From crafting a compelling investor narrative to ensuring regulatory compliance, every step is carefully calibrated to maximize value for the company and its stakeholders.
Looking ahead, Chong sees a promising future for XRP Healthcare. “Our goal for XRP Healthcare is to have them listed in the U.S. within five years,” he stated confidently. With ARC Group’s guidance, the company is well on its way to becoming a major player in the public markets, blending innovation in healthcare and blockchain with the credibility of a publicly listed entity.
Healthcare companies are increasingly seeking public listings, reflecting the sector’s growth and resilience. “If you look at NASDAQ, you’ll see a constant stream of healthcare companies, whether they’re in pharmaceuticals or biomedicine,” Chong observed. Mergers and acquisitions are also driving expansion in the sector, further fueling interest in IPOs and RTOs.
From East to West: The rise of cross-border transactions
ability to act as a bridge positions ARC Group as a trusted partner in facilitating East-to-West transactions.
Emerging trends: IPOs, SPACs, and ESG
The capital markets are dynamic, and Chong highlighted several trends shaping the industry. For IPOs, he emphasized the importance of timing and company readiness. “Companies are increasingly focusing on pre-IPO readiness, ensuring their governance and financials are solid,” Chong noted. Cross-border IPOs, particularly from Asia, are on the rise as companies seek to tap into U.S. markets for global visibility and investment.
Special Purpose Acquisition Companies (SPACs) also remain a popular vehicle for going public, thanks to their speed and flexibility. However, Chong pointed out that their success hinges on the post-DeSPAC merger process. “Due diligence, transparency, and alignment with market expectations are key to success in this space,” he explained.
Environmental, Social, and Governance (ESG) considerations are another major trend. “Investors are prioritizing sustainable and socially responsible businesses,” Chong said. Companies with strong ESG practices are not only attracting more attention but also commanding higher valuations, reflecting the growing demand for ethical investments.
As capital flows between the East and West increase, the ability to navigate diverse markets has become a critical success factor. “From our group’s perspective, several factors facilitate listing companies from East to West,” Chong explained. ARC Group, with headquarters in Shanghai and 12 offices worldwide (including the Americas, Europe, Middle East and Asia) , brings a decade of experience in global markets while maintaining a strong global presence.
“Our global presence allows us to offer insights into local markets and address cultural nuances,” he continued. By having teams on the ground in key regions, ARC Group bridges gaps in time zones, language, and business practices. “Dealing with a time difference between Asia and the U.S. can be challenging, but we’re there to facilitate communication, help with calls, and ensure that business proceeds smoothly,” Chong added. This
RTOs: A cost-effective alternative
Reverse takeovers (RTOs) have gained traction as a faster and more cost-effective alternative to traditional IPOs. Chong shared his experience with RTOs, emphasizing their potential in markets with stricter regulatory requirements. “More companies are considering this route due to its speed and costeffectiveness,” he said. However, success depends on finding the right target company or shell to ensure smooth governance.
While details of ongoing RTO transactions remain confidential, Chong expressed confidence in their strategic value. “I’ve worked on several RTOs within our group. Once they’re public, you’ll definitely hear about them,” he shared.
XRP Healthcare Expands Global Presence with Trademark Registrations Across 27 European Countries
XRP Healthcare, a leader in blockchain-powered healthcare solutions, continues its global expansion by securing its official trademark in all 27 European Union (EU) countries. This milestone solidifies the company’s commitment to transforming the healthcare industry through mergers and acquisitions (M&A), digital innovation, and financial accessibility. With legal protection now in place across key markets like Germany, France, Italy, and Spain, XRP Healthcare strengthens its brand identity and positions itself for accelerated growth in one of the world’s most influential economic regions.
• Stronger Investor Confidence – Investors and stakeholders can trust the company’s credibility and long-term vision, knowing that its brand is legally protected.
• Foundation for Expansion – With legal barriers minimized, XRP Healthcare is positioned to establish new partnerships and launch largescale healthcare initiatives across Europe.
The Importance of Trademark Protection in Healthcare Trademarks play a critical role in protecting brand integrity, especially in highly regulated industries like healthcare. For a company leveraging blockchain technology to streamline healthcare services, securing exclusive rights to its brand ensures trust, credibility, and legal recourse against counterfeiting or unauthorized use. With a recognized trademark, XRP Healthcare can safeguard its intellectual property while reinforcing its legitimacy in new markets.
Why This Matters
Securing trademark rights across Europe brings several advantages:
• Legal Protection – XRP Healthcare’s brand is now safeguarded from unauthorized use in all 27 EU countries, preventing potential fraud or misrepresentation.
• Growing Global Footprint – This milestone aligns with XRP Healthcare’s strategy of expanding into multiple regions, reinforcing its presence as a leader in blockchain-driven healthcare solutions.
EUIPO Grants XRP Healthcare Important Legal Protection
The European Union Intellectual Property Office (EUIPO) has given XRP Healthcare legal protection under two key categories, strengthening its role in blockchain-powered healthcare. Class 9 protects its downloadable software and digital tokens for healthcare payments, prescriptions, and medical services.
Additionally, Class 44 protects its pharmaceutical services, medication dispensing, and healthcare consultations. This approval secures XRP Healthcare’s rights across Europe, ensuring legal safety and industry recognition. With this protection, the company can keep developing digital healthcare solutions while safeguarding its intellectual property. It also builds trust and security for users and partners in the growing digital healthcare industry.
Global Expansion: Beyond Europe XRP Healthcare’s expansion is not limited to Europe. The company has already secured trademark registrations in:
• The United Kingdom – Establishing a strong foundation in one of the world’s major financial and healthcare markets.
• The United Arab Emirates (UAE) – Expanding into the Middle East, a rapidly growing hub for digital health solutions and blockchain innovation.
• Uganda – Strengthening its presence in Africa, where healthcare accessibility and technological integration are crucial for improving patient outcomes.
The Strategic Role of Trademarking in Business Growth
In a competitive global marketplace, trademark registrations do more than just offer legal
protection—they enable business expansion. By securing its brand in key regions, XRP Healthcare enhances its ability to:
• Engage in cross-border partnerships with healthcare providers, regulatory bodies, and technology innovators.
• Attract institutional investors who seek assurance in a brand’s market stability and legal standing.
• Scale its operations to introduce blockchainbased healthcare solutions in new territories with minimal regulatory friction.
With Europe, the UK, UAE, and Uganda secured, XRP Healthcare is well-positioned for further global expansion. As the company continues to grow, its focus remains on delivering innovative healthcare services that are efficient, accessible, and financially inclusive.
27 EU countries where XRP Healthcare is trademarked
From Grassroots to Global Impact: Dr. Peter Waiswa’s Life, Legacy and Giving Back to the Community
BY HELLEN MUCHERU
Dr. Peter Kyobe Waiswa: Ugandan researcher, medical doctor, academic administrator, and author of From Grassroots to Global Impact
The XRP Healthcare Magazine Press team recently had the pleasure of speaking with a man of many titles—some official, some honorary, and some, well, straight from birth! Dr. Peter Waiswa’s journey began with not just one but two titles right out of the womb. As the firstborn twin, he was given the special name “Waiswa,” and to top it off, he was born into a royal clan—meaning we’re technically in the presence of a prince! Over the years, he’s collected a few more titles—Doctor, Professor—but he doesn’t dwell on them. Instead, he focuses on the impact he can make. His latest book, From Grassroots to Global Impact, is not just about the journey of one man but a roadmap for aspiring change-makers everywhere. So, as we sit down with the professorprince who quite literally had a partner in life from the cellular stage, let’s dive into his remarkable story.
Hellen: We’d love to hear more about your inspiration behind writing the book and the key message you hope readers will take away from it. I think that would provide a great starting point for our conversation.
Dr. Waiswa: Thank you so much. In fact, you’ve already seen parts of this book before—I remember sharing a chapter with you when you wrote about me last time. In a way, the essence of my story aligns with what you captured, though in a more condensed form. This book has been in the making for some time.
The book targets young people, professionals, and parents, conveying two messages: success is possible regardless of background, and true success is about giving back. My hope is to inspire both personal and collective progress.
Hellen: Another important lesson you emphasize is the need to develop confidence and stand up for what is right. Can you elaborate on that?
Dr. Waiswa: Absolutely. As a student, I often challenged my teachers—not in a disruptive way, but to question and improve the system. This sometimes got me into trouble, but it helped me develop critical thinking and leadership skills. I believe young people should be encouraged to stand up for themselves and others in a constructive and meaningful way.
Its title, From Grassroots to Global Impact, reflects a key theme—how someone from a humble background can make a meaningful global contribution. But beyond that, it’s about how professionals can stay connected to and uplift their communities.
In Africa, we face immense challenges, yet many highly trained professionals rarely return to support the communities that shaped them. I wrote this book to share my journey—the struggles I faced and the strategies I used to overcome them. One core message is encouraging children to think critically. In our culture, respect for elders is vital, but curiosity is often mistaken for defiance. I emphasize the need to nurture inquisitive minds.
I see this in my own children. They challenge me on many things, and I welcome it. Many times, what we perceive as stubbornness in children is actually intelligence that is not being properly nurtured. Some children are labeled as disruptive simply because they are not sufficiently challenged by the curriculum, which is often designed for the average student. Instead of providing them with more stimulating opportunities, they are misjudged, disciplined, or even expelled.
I personally experienced this. I was thrown out of school multiple times and almost didn’t make it. But what I advocate for—and what I highlight in my book—is that we must strive to understand so-called “resistant” children. Why do they behave the way they do? Are they truly disruptive, or are they just seeking intellectual stimulation? Instead of dismissing them, we should support and guide them.
Beyond education, another key message in my book is that professionals, regardless of their field, should find ways to give back to their communities. Whether you are a journalist, a doctor, or an academic, you can use your expertise to create a meaningful impact. For example, instead of just covering political stories, a journalist could highlight community-driven successes that inspire change.
Hellen: How did your background in public health and your role as a professor influence your ability
to navigate different spaces and advocate for meaningful projects?
Dr. Waiswa: In my own work, I use my understanding of public health and my credibility as a professor to navigate different spaces and advocate for meaningful projects. Recently, I helped secure land in the city to establish a medical school—despite not being part of the official committee.
I simply approached the local leaders and asked, If you don’t invest in a medical school, what will you use the land for? More residential houses instead of essential public institutions? They listened. As a result, the university committee approached the state land board, made a request, and successfully obtained the land.
Similarly, I helped facilitate land acquisition for a Heart Institute in Jinja City. They were struggling to get approval, so I spoke to key decision-makers, explaining the long-term benefits of having such an institution in the region. A simple WhatsApp message from me led the hospital director to convene the board, and they ultimately decided to allocate the land.
These are the kinds of impactful contributions professionals can make. Many people believe that achieving change requires corruption or bureaucratic struggles, but sometimes, all it takes is credibility, advocacy, and the right conversations with the right people.
scientific papers, they mainly reach academics. This book translates my insights into everyday language to impact a broader audience.
Beyond sharing my journey, a key goal of this book is to support education for underserved children. We launched One Village at a Time to empower communities through education and development. While international aid exists, real change begins with us. That’s why we started in my own village, Naigobya, Uganda. Though it has produced successful professionals, today, over 60% of children drop out of school—not due to lack of potential but lack of opportunity.
Our approach is direct engagement, not just charity. We collaborate with communities to address their challenges—whether in education, income, or health—by supporting sustainable solutions. A major success has been our partnership with the Rotary Club to build an Early Childhood Development Center at my former school.
The book’s core message is that success is not individual; it’s a shared responsibility. By remembering our roots and working together, we can create lasting change—one village at a time.
Hellen: You’ve published over 200 academic papers, but this book is different. It’s deeply personal and tied to your vision for change, not just in your community but beyond. What makes it so special to you?
Hellen: It sounds like your book is more than just a personal narrative—there’s a strong element of reflection and lessons for others. Could you elaborate on that?
Dr. Waiswa: My story is not just about overcoming challenges but about finding meaning in those experiences and helping others do the same. The book reflects on my journey—education, professional growth, and the lessons I’ve learned. It’s not just a personal account of struggles and successes but a guide to inspire others.
At 53, I see this as my halftime story, with more chapters to come. While I’ve published over 200
Dr. Waiswa: This book is special to me for several reasons. First, it captures my journey—from growing up with my parents and twin brother to where I am today. That personal touch makes it relatable and accessible.
Second, it simplifies my experiences. Many people acknowledge my success, saying, Peter has done well, but few ask, How did you make it? What lessons can we learn? This book answers those questions, offering insights that others can apply to their own lives.
Third, it challenges the perception that I am solely an academic. I want people to see my broader
impact—beyond research and academia. I once wrote a paper, We Need to Self-Recognize, emphasizing that success isn’t just about personal achievements but about actively improving our communities.
This book also provides context for my global work. Right now, I’m in Kampala, but I was supposed to be in North Carolina for a major global meeting. People often assume we come from privileged backgrounds, without understanding our struggles and responsibilities.
Ultimately, this book tells my full story—not just my academic success, but my challenges, motivations, and commitment to uplifting others. By sharing our journeys, we can inspire real change.
Hellen: Now that you’ve published this book, how does it feel knowing that people in your circle—your family, your peers, even your children—can now see your life journey in writing and understand what you’ve been through?
Dr. Waiswa: To be honest, this part has been a bit challenging for me. I’ve never been the kind of person who talks much about myself. I tend to focus on the work at hand rather than sharing my own story.
Right now, I have this book, but I haven’t widely shared it yet. So far, I’ve only given it to my family, a small group of mentees, and one of my mentors—a Swedish professor. But beyond that, I’ve been struggling with the question of how to take it to a larger audience.
understand where someone comes from or what they’ve overcome. I think this book provides that opportunity. I just have to put it out there and let it find the people who need to read it.
Hellen: Where will your book be available? If someone wants to read it, research your journey, or be inspired, how can they find it?
Dr. Waiswa: First of all, I wanted my book to stand out—not just in its content, but also in how I introduce it to the world. I’m honored to have received an endorsement from the King of Busoga, Uganda’s second-largest region after Buganda. The king appreciates the work I do in communities, and his endorsement means a lot to me.
As for availability, the book will be sold in major bookshops across Kampala, including: Aristoc Booklex, Bookpoint Bugolobi, Uganda Bookshop, and Mukono Bookshop.
There’s always that fear—something I believe many academics and professionals struggle with—of how people will perceive it. Some may think, Oh, now he sees himself as great, writing about his own life. Others might not see the value in the story. But then there are also those who will be inspired, including my students, who might be encouraged to write their own stories.
One thing I’ve realized is that even among colleagues—people who work together daily—we rarely know each other’s life stories. You can sit in the same office for years, even socialize, but never truly
It will also be available on Amazon, and I’ll share it on my LinkedIn page, where I have a strong network of professionals. Additionally, for direct purchases, arrangements can be made by contacting me via WhatsApp at +256772405357, email pwaiswa@ musph.ac.ug, or through my LinkedIn profile: https:// www.linkedin.com/in/peter-waiswa-2a015510/. You can also find updates on my X handle @waiswap.
Beyond its distribution, one of the most important aspects of this book is its impact—I plan to use proceeds from sales to support education in my rural home area, aligning with my broader goal of giving back and creating opportunities for future generations.
XRPH AI App launches, offering instant multilingual medical guidance
XRP Healthcare has officially launched the XRPH AI App, a multilingual digital assistant designed to deliver instant, personalized medical guidance to users worldwide.
Developed by the company’s in-house AI team, the app provides tailored health advice across traditional, holistic, and conventional treatments. It is available for free download on Google Play, the App Store, and XRPH.ai.
The app offers a range of standout features, including custom personal training programs based on factors like weight, height, ethnicity, injuries, and dietary preferences. It also provides users with insights into meditation techniques, nutritional guidance, and advanced treatments for terminal illnesses such as cancer.
Additional features include instant health answers, multilingual support to overcome language barriers, and secure, private chats with anonymized data. The AI tool offers medical guidance in Luganda, Swahili,
Kinyarwanda, French, and English. With structured diet and wellness programs, the app empowers users to align health goals with their lifestyles. This innovation forms part of XRP Healthcare’s broader strategy to integrate artificial intelligence and blockchain technology into the healthcare sector. The company is focused on improving access to healthcare by acquiring medical facilities in Africa and enhancing healthcare delivery on the continent.
XRP Healthcare’s leadership team brings exceptional expertise to this mission. CEO Kain Roomes stated in a press release, “XRPH AI marks the beginning of a new era in digital healthcare. Our mission is to break down barriers to medical access by leveraging AI and blockchain, ensuring that quality healthcare is available to everyone, regardless of location or financial status.”
COO and Co-Founder Laban Roomes added, “Healthcare should have no borders. With XRPH AI, we’re making instant, secure, and reliable medical advice universally accessible. This is a revolutionary step towards empowering people to take control of their health with confidence and ease.”
A new standard in health data protection
Safeguarding personal health information is more important than ever in today’s digital age because health data privacy and security have become paramount concerns. As healthcare systems increasingly integrate digital tools and artificial intelligence, safeguarding personal medical information is not just an option, but a necessity. With the rise of cyber threats and data breaches, protecting sensitive health records requires cuttingedge encryption, strict privacy protocols, and robust cybersecurity measures.
XRPH AI is changing the narrative about health data security by implementing state-of-the-art encryption and anonymization technologies. Every interaction, from discussing symptoms to receiving
AI-driven healthcare insights, is fully encrypted and anonymized. This ensures that unauthorized access is prevented, allowing individuals to engage with healthcare services in a safe and confidential environment. Unlike traditional healthcare platforms that may store personal data in centralized databases—making them vulnerable to breaches— XRPH AI utilizes decentralized security frameworks to offer an added layer of protection.
One of the core concerns in digital healthcare is data traceability. Many online platforms collect user information, creating risks of data misuse, unauthorized sharing, or cyber-attacks. With XRPH AI, privacy remains at the forefront. No personally identifiable information (PII) is stored or shared, guaranteeing users complete control over their health data. Whether engaging in virtual consultations, tracking health metrics, or receiving personalized medical advice, every session remains confidential.
Leveraging AI without compromising security
Artificial Intelligence is transforming healthcare by enhancing diagnostic accuracy, personalizing treatment plans, and optimizing patient care. However, AI’s efficiency depends on access to vast amounts of health data, raising concerns about how such data is handled and protected. XRPH AI solves this challenge by implementing on-device AI processing whenever possible, minimizing data exposure. Advanced zero-knowledge encryption ensures that even when AI-driven analytics are performed, no raw health data is accessible to third parties.
Building trust in digital healthcare Trust is a critical factor in the adoption of digital healthcare solutions. Patients and healthcare providers need assurance that medical information remains protected from cyber threats and unauthorized surveillance. XRPH AI not only meets but exceeds global health data protection standards, providing users with confidence in a fully secure and private healthcare experience.
Medical image analysis
The XRPH AI App also allows users to analyze medical images and gain valuable insights. This new feature helps doctors and patients detect
diseases early, improve diagnosis, and create better treatment plans. By using AI, the app makes medical image analysis faster and more accurate, reducing human errors and increasing reliability. It also provides easy access to advanced healthcare tools, making high-quality diagnostics available to more people. In today’s world, where AI is changing healthcare, this innovation empowers users to make informed health decisions.
Leading the way: XRP Healthcare’s pioneering innovations in blockchain and healthcare
The intersection of blockchain technology and healthcare is redefining the future of medical services, bringing greater transparency, efficiency, and accessibility to patients and providers alike. At the forefront of this revolution is XRP Healthcare,
a trailblazing platform that leverages the XRP Ledger (XRPL) to transform the global healthcare landscape. As the first healthcare platform built on the XRPL, XRP Healthcare is setting new standards for innovation, security, and affordability in the industry.
Transforming Healthcare with Blockchain Blockchain technology has emerged as a game-changer for healthcare, offering secure, immutable, and decentralized solutions for managing medical data, streamlining transactions, and improving patient outcomes. XRP Healthcare harnesses the power of the XRP Ledger, a fast, scalable, and energy-efficient blockchain, to create a seamless ecosystem where patients, healthcare providers, and pharmaceutical companies can interact with unprecedented efficiency.
By utilizing blockchain, XRP Healthcare ensures data integrity, privacy, and real-time access to medical records while eliminating costly intermediaries. This technology is particularly crucial in regions with fragmented healthcare systems, where access to reliable and verifiable medical data can be a challenge.
A World-First: The XRP Healthcare Prescription Savings Card
One of XRP Healthcare’s most disruptive initiatives is its Prescription Savings Card, the first of its kind in the crypto space. This innovation aims to bridge the gap between traditional healthcare costs and digital financial solutions, offering significant discounts on medications for patients. By integrating blockchain with prescription savings, XRP Healthcare provides a practical solution to rising pharmaceutical costs while enhancing financial inclusivity.
The Prescription Savings Card offers discounts of up to 80% on prescription and over-the-counter medications, making essential healthcare more affordable for millions. Unlike traditional savings programs, there are no fees, subscriptions, or hidden
costs—the card is completely free to download via the XRPH app. With AI-driven guidance embedded within the app, users receive personalized healthcare insights and recommendations tailored to their needs.
The card is particularly beneficial for individuals managing chronic conditions such as diabetes, high blood pressure, and mental health disorders, where continuous medication use is necessary. Accepted at over 68,000 pharmacies, including major chains like Walmart, Walgreens, and CVS, the card provides widespread access to discounted prescriptions. Moreover, when customers present the card at a participating pharmacy, they are rewarded with a token that is directly deposited into their XRPH Mobile Wallet, further incentivizing its use while integrating digital finance into everyday healthcare transactions.
Pioneering AI Integration on the XRP Ledger
Beyond blockchain, XRP Healthcare is also the first project on the XRPL to integrate artificial intelligence (AI), marking a significant milestone in the convergence of AI and decentralized healthcare. This integration enhances predictive analytics, personalized healthcare insights, and automated diagnostics, making healthcare services smarter and more accessible.
Through AI-driven analytics, XRP Healthcare can identify health trends, optimize patient care, and provide real-time recommendations, empowering users to take control of their well-being. AI integration also streamlines administrative processes, reducing inefficiencies and enhancing the overall healthcare experience.
By merging financial efficiency with advanced healthcare solutions, XRP Healthcare is breaking barriers, enhancing accessibility, and paving the way for a more inclusive and technologically driven healthcare ecosystem.
By utilizing blockchain, XRP Healthcare ensures data integrity, privacy, and realtime access to medical records while eliminating costly intermediaries.
